Remove Clinical Trials Remove Generic Drugs Remove Generic Pharmaceutical
article thumbnail

Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide

XTalks

Novartis’ biosimilars and generics drug division Sandoz has announced a new global campaign called ‘Act4Biosimilars’ to help raise awareness about biosimilars and increase their adoption by at least 30 percent in over 30 countries by the year 2030. Related: Cyltezo Becomes First FDA-Approved Interchangeable Humira Biosimilar.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

GSK’s Top 5 Best-Selling Drugs of 2022: 1) Shingrix (zoster vaccine recombinant, adjuvanted) Shingrix, with 2022 sales of £2.96 Clinical trials have shown that the vaccine is 90 percent effective in preventing shingles for individuals aged 50 and over. Teva Pharmaceutical Industries Ltd. billion ($3.65 billion ($2.85

Sales 98
article thumbnail

‘Right shoring’ API production in Europe

Pharmaceutical Technology

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report.